Investors have a final chance today to buy shares in 33 companies, including Mahindra & Mahindra, Tech Mahindra, and Union Bank, to qualify...

CDSCO still faces challenges like chronic understaffing, gaps in technical skills, weak lab infra and fragmented approvals. About a decade ...

Telangana is charting a new course to elevate Hyderabad into a global drug discovery hub. The state is fostering an integrated ecosystem by...

It is quite likely that the news cycle this and the next week will be about the direction of US interest rates and yield. If that turns out...

Karnataka Chief Minister D K Shivakumar has warned the pan masala and gutkha industry of an outright ban if any intoxicating substances are...

Prime Minister Modi's historic Seychelles address highlighted maritime bonds, while India and the island nation inked 19 cooperation outcom...

Foreign investors are reallocating capital away from India towards markets like Taiwan and South Korea that offer stronger exposure to AI a...

India and Switzerland are boosting science and technology ties, combining India's scale with Swiss innovation for citizen solutions and sta...

Indian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...

Assam's public health system is now among the nation's best, with significant improvements in Maternal Mortality Ratio, now at 84, below th...

Initial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...

In a bold move, IndiaMART is ramping up its AI-related budget, with plans to double its expenditure biannually. This funding will be direct...

Indian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...

Niti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...

India's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...

India's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...

Government's Minimum Import Price (MIP) initiative to boost domestic drug makers faces a slow start. Despite setting price thresholds for k...